These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

559 related items for PubMed ID: 26257512

  • 21. Binding pattern of the long acting neuraminidase inhibitor laninamivir towards influenza A subtypes H5N1 and pandemic H1N1.
    Meeprasert A, Khuntawee W, Kamlungsua K, Nunthaboot N, Rungrotmongkol T, Hannongbua S.
    J Mol Graph Model; 2012 Sep; 38():148-54. PubMed ID: 23079644
    [Abstract] [Full Text] [Related]

  • 22. H274Y's Effect on Oseltamivir Resistance: What Happens Before the Drug Enters the Binding Site.
    Yusuf M, Mohamed N, Mohamad S, Janezic D, Damodaran KV, Wahab HA.
    J Chem Inf Model; 2016 Jan 25; 56(1):82-100. PubMed ID: 26703840
    [Abstract] [Full Text] [Related]

  • 23. Molecular basis of drug resistance in A/H1N1 virus.
    Vergara-Jaque A, Poblete H, Lee EH, Schulten K, González-Nilo F, Chipot C.
    J Chem Inf Model; 2012 Oct 22; 52(10):2650-6. PubMed ID: 22978683
    [Abstract] [Full Text] [Related]

  • 24. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
    Wang SQ, Du QS, Huang RB, Zhang DW, Chou KC.
    Biochem Biophys Res Commun; 2009 Aug 28; 386(3):432-6. PubMed ID: 19523442
    [Abstract] [Full Text] [Related]

  • 25. Neuraminidase inhibitor-resistant recombinant A/Vietnam/1203/04 (H5N1) influenza viruses retain their replication efficiency and pathogenicity in vitro and in vivo.
    Yen HL, Ilyushina NA, Salomon R, Hoffmann E, Webster RG, Govorkova EA.
    J Virol; 2007 Nov 28; 81(22):12418-26. PubMed ID: 17855542
    [Abstract] [Full Text] [Related]

  • 26. Molecular dynamics simulation of oseltamivir resistance in neuraminidase of avian influenza H5N1 virus.
    Shu M, Lin Z, Zhang Y, Wu Y, Mei H, Jiang Y.
    J Mol Model; 2011 Mar 28; 17(3):587-92. PubMed ID: 20517627
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Source of oseltamivir resistance due to single E119D and double E119D/H274Y mutations in pdm09H1N1 influenza neuraminidase.
    Hanpaibool C, Leelawiwat M, Takahashi K, Rungrotmongkol T.
    J Comput Aided Mol Des; 2020 Jan 28; 34(1):27-37. PubMed ID: 31773463
    [Abstract] [Full Text] [Related]

  • 31. Identification of neuraminidase inhibitors against dual H274Y/I222R mutant strains.
    Hsu KC, Hung HC, HuangFu WC, Sung TY, Eight Lin T, Fang MY, Chen IJ, Pathak N, Hsu JT, Yang JM.
    Sci Rep; 2017 Sep 26; 7(1):12336. PubMed ID: 28951584
    [Abstract] [Full Text] [Related]

  • 32. Understanding of known drug-target interactions in the catalytic pocket of neuraminidase subtype N1.
    Malaisree M, Rungrotmongkol T, Decha P, Intharathep P, Aruksakunwong O, Hannongbua S.
    Proteins; 2008 Jun 26; 71(4):1908-18. PubMed ID: 18175324
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Structural analysis of the novel influenza A (H7N9) viral Neuraminidase interactions with current approved neuraminidase inhibitors Oseltamivir, Zanamivir, and Peramivir in the presence of mutation R289K.
    Tran-To Su C, Ouyang X, Zheng J, Kwoh CK.
    BMC Bioinformatics; 2013 Jun 26; 14 Suppl 16(Suppl 16):S7. PubMed ID: 24564719
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus.
    Du QS, Wang SQ, Chou KC.
    Biochem Biophys Res Commun; 2007 Oct 19; 362(2):525-31. PubMed ID: 17707775
    [Abstract] [Full Text] [Related]

  • 39. Novel binding patterns between ganoderic acids and neuraminidase: Insights from docking, molecular dynamics and MM/PBSA studies.
    Yang Z, Wu F, Yuan X, Zhang L, Zhang S.
    J Mol Graph Model; 2016 Apr 19; 65():27-34. PubMed ID: 26905206
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.